Jacqueline Claire Lupo

Chief Executive Officer presso LOPHOS HOLDINGS INC.

Patrimonio netto: 660 000 $ in data 30/04/2024

39 anni

Consumer Non-Durables

Health Technology

Profilo

Jacqueline Claire Lupo is the founder of Lophos Pharmaceuticals Corp., where she holds the title of President, CEO & Director since 2021.
She is also the founder of Canalytica Corp.
Ms. Lupo's current job is as the Chief Executive Officer & Director at Lophos Holdings, Inc. since 2021.
Additionally, she is currently working as a Manager at Northern Green Canada, Inc.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
LOPHOS HOLDINGS, INC. 14.90%	12/02/2024	11 000 000 ( 14.90% )	660 000 $	30/04/2024

Posizioni attive di Jacqueline Claire Lupo

Società	Posizione	Inizio
LOPHOS HOLDINGS INC.	Chief Executive Officer	23/12/2021
Lophos Pharmaceuticals Corp. Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The private company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022.	Founder	01/01/2021
Northern Green Canada, Inc.	Corporate Officer/Principal	-

Tutte le posizioni attive di Jacqueline Claire Lupo

Precedenti posizioni note di Jacqueline Claire Lupo

Società	Posizione	Fine
Canalytica Corp.	Founder	-

Vedi nel dettaglio l'esperienza di Jacqueline Claire Lupo

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jacqueline Claire Lupo

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Northern Green Canada, Inc.	Consumer Non-Durables
Lophos Pharmaceuticals Corp. Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The private company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022.	Health Technology
Lophos Holdings, Inc.
Canalytica Corp.

Vedi le connessioni aziendali